Board of Directors
Richard
Laferrière
Chairman of the Board of Directors, Warnex Inc.
Executive Chairman, Extenway Solutions Inc.
Mr. Laferrière has been Chairman of the Board of Warnex since 1996. Mr. Laferrière has been Executive Chairman of Extenway Solutions Inc. since May 2008 and Chairman of the Board of FRV Media Inc. since May 2008. From 2000 to 2008, Mr. Laferrière was President and Chief Executive Officer as well as Director of FRV Media Inc. He was also a shareholder and member of the Board of “HR Stratégie”, a private equity firm, from 2000 to 2006. He was co-founder and President of Groupe Coscient from 1978 to 1999. In 2007, Mr. Laferrière joined the Board of Directors of Fronsac Capital Inc.
Mark
Busgang
President, Chief Executive Officer and Director, Warnex Inc.
Mr. Busgang has been President and Chief Executive Officer of Warnex since February 1998. From 1993 to 1996, he was President of Pharmetics Ltd. During this period, he also co-founded Theratechnologies Inc. and served as Vice President of Operations. Mr. Busgang is presently Director of Laval Technopole, a member of the World Presidents' Organization and actively involved in many community and charitable organizations.
Louis
Lacasse
President, Genechem Management Inc.
Mr. Lacasse has been President of GeneChem Management Inc. since 1997 and Managing Partner of AgeChem Financial Inc. since 2006. Mr. Lacasse is currently on the boards of directors of Methylgene Inc. and Calyx Bioventures. He has previously served on the boards of directors of many private and public companies including BioChem Pharma Inc., Axcan Pharma Inc., Targeted Genetics Inc., and Idun Pharmaceuticals Inc.
Dr.
Jacques Gagné
Consultant
Dr. Gagné is a former Professor (1972 to 2002) and Dean (1982 to 1990) of Pharmacy at Université de Montréal. Since April 2001, Dr. Gagné serves as a consultant to several companies in the biotechnology and healthcare fields. Among others, he is Chairman of the Québec Biotechnology Inovation Center (QBIC) and President of the "Fond d’assurance responsabilité de l’Ordre des pharmaciens du Québec".
Gilles Gagnon
Consultant
Mr. Gagnon serves as a consultant to several companies in the biopharmaceutical and healthcare fields. Mr. Gagnon spent 25 years in the management of healthcare related organizations in both hospital administration (8 years) and in the pharmaceutical industry (17 years). Between 1999 and 2007, Mr. Gagnon worked at Aeterna Zentaris, a biopharmaceutical company focused on oncology and endocrinology, where he held the positions of Vice-President, Business Development (1999-2001), President and Chief Operating Officer (2001-2003) and President and Chief Executive Officer (2003-2007). Mr. Gagnon is also Acting President and Director of Ceapro Inc.
Mattie Chinks
President, Avmor Ltd.
Mr. Mattie Chinks is President of Avmor Ltd., a leading company in the development and manufacturing of professional cleaning and sanitation products and cleaning solutions. He has over 25 years experience in sales and marketing, product development, general management and corporate development. Mr. Chinks has previously served as President and International Director of the International Sanitary Supply Association and currently sits on the Board of Directors of The Royal Victoria Hospital Foundation and Cannon Hygiene Canada.
Michel Lassonde
Consultant
Mr. Lassonde has been a consultant and director of various companies since March 2008. Mr. Lassonde has also been President, CEO and Director of Fronsac Capital Inc. since August 2008. From September 1991 to March 2008, he was a Court of Québec judge. Previously, Mr. Lassonde practiced law for over 25 years. He has a master’s degree in international law from New York University.
Hon. Baljit S. Chadha
President, Balcorp Ltd.
Baljit Singh Chadha, PC, is president of Balcorp Limited, an international trade and marketing firm, which he founded in 1976 and built into a successful company with about $100 million in sales and offices in Montreal, New Delhi and Mumbai. Balcorp has diversified interests in agri-food products, forestry products, minerals and services. Mr. Chadha is also a well known philanthropist and a leader of the Indian community in Canada. He has been a key player in a number of international trade missions and treaty development processes. He also sits on the Board of Governors of Concordia University, has advised the Office of the Mayor of Montreal on Indo-Canadian affairs and has served on the advisory board of the Indo-Canada Chamber of Commerce. In 2003, he was appointed by Prime Minister Jean Chrétien to the Security Intelligence Review Committee as well as the Queen's Privy Council for Canada.
Dr. Richard Lacombe
Consultant
Dr. Richard Lacombe is a consultant with over 30 years of experience with pharmaceutical, biotech, and contract research organization (CRO) companies. Dr. Lacombe was Vice-President, Clinical Affairs of BioSyntech Inc. from 2006 to 2008. He worked as an independent consultant for biotech companies from 2004 to 2006, and was President and Chief Executive Officer of Virocell Inc. from 2002 to 2004. Dr. Lacombe obtained a Ph.D. in Pharmacology from University of Montréal and a M.B.A. from University of Sherbrooke.
